// App-Quantinova.ai

DNAR-12 : COMBINING TUMOUR TREATING FIELDS WITH THERAPEUTIC DNA DAMAGE RESPONSE INHIBITORS TO INCREASE POTENCY IN HIGH-GRADE GLIOBLASTOMAS USING CLINICALLY RELEVANT EX-VIVO GLIOMA STEM CELL MODELS

Researchers

Presenter

  • Aurelie Vanderlinden

Principal Investigators

  • Ola Rominiyi

  • Spencer Collis

  • Callum Jones

  • Katie Myers

  • Connor McGarrity - Cottrell

Medical Centers

  • University of Sheffield, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High-Grade Gliomas

  • Glioblastoma

  • Brain cancer

  • Gliomas

  • Solid malignancies

Biomarkers

  • Ataxia Telangiectasia And Rad3-Related Protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved